| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.26B | +8.3% |
| Cost of Revenue | $2.72B | +6.2% |
| R&D Expense | $686.0M | +11.7% |
| SG&A Expense | $2.32B | +7.8% |
| Interest Expense | $225.0M | -5.9% |
| Pre-tax Income | $3.13B | +6.7% |
| Income Tax | $637.0M | +6.9% |
| Net Income | $2.49B | +6.1% |
| EPS (Basic) | $5.47 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.32B | +0.9% |
| Inventory | $2.31B | -10.1% |
| Current Assets | $5.99B | -5.6% |
| Total Assets | $14.24B | -0.3% |
| Current Liabilities | $3.41B | +80.6% |
| Long-term Debt | $5.22B | -20.5% |
| Total Liabilities | $9.47B | +1.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.95B | +25.5% |
| Capital Expenditures | $655.0M | -10.5% |
| Investing Cash Flow | -$315.0M | +59.5% |
| Financing Cash Flow | -$2.66B | +14.4% |
| Free Cash Flow | $2.30B | +41.8% |
| +7.7% |
| EPS (Diluted) | $5.47 | +7.9% |
| Stockholders' Equity |
| $4.77B |
| -4.5% |